ERBB2 and triple-negative breast carcinoma: We also tested the binding of the bsAb to MDA-MB-231, a triple-negative breast cancer (TNBC) cell line (negative for the estrogen receptor, progesterone receptor, and HER2) with a low HER2 level [62,63,64,65].